Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study highlights risks of subcutaneous ureteral bypass placement
Major complications from SUB occurred in 48 per cent of the cats studied.

Researchers analyse the medical records of 95 cats fitted with SUB devices.

Subcutaneous ureteral bypass (SUB) placement is associated with a high complication rate, according to new research.

The study, published in the Journal of Small Animal Practice (JSAP), found that most of these complications are manageable, resulting in an average survival time of over two years. It also suggests that imaging techniques, such as fluoroscopy, are useful in identifying complications. 

In the study, researchers analysed the medical record of  95 cats fitted with SUBs between April 2012 and June 2017. The information recorded included imaging modality used for diagnosis, whether urethral catheterisation was performed and whether obstruction was uni- or bilateral. 

They found that minor complications - defined as infection or technical problem which resolved with none or minor treatment - occurred in 19 per cent of the cats. Major complications - defined as infection or technical problem resulting in revision surgery, removal of the SUBs or death/euthanasia – occurred in 48 per cent of the cats. Eleven per cent of cats analysed in the study did not survive to discharge. 

Dr Nicola Kulendra, lead author for the paper said: “A significant association between long-term survival and creatinine at presentation was identified. The median survival time for cats presenting with creatinine concentration ≥440 μmol/L (International Renal Interest Society stage acute kidney injury (AKI) 4 and 5) was 530 days, compared to a median survival time of 949 days for those cats presenting with creatinine <440 μmol/L (International Renal Interest Society stage AKI 1–3).”

JSAP editor Nicola Di Girolamo, concluded: “Veterinary medicine is advancing fast and it is exciting to see treatment options that just a decade ago were rarely considered are now accessible to many of our patients. Furthermore, it is excellent to see the veterinary sector is publishing articles of this nature, demonstrating the risks and complications of a procedure, to support proper discussion with owners and referring veterinarians.”

Image © BSAVA Manual of Canine and Feline Abdominal Surgery 2nd Ed.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.